These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 9484866)

  • 21. Randomized, double-blind study of grepafloxacin versus amoxycillin in patients with acute bacterial exacerbations of chronic bronchitis.
    Langan CE; Cranfield R; Breisch S; Pettit R
    J Antimicrob Chemother; 1997 Dec; 40 Suppl A():63-72. PubMed ID: 9484875
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The fluoroquinolones after ciprofloxacin and ofloxacin.
    Hooper DC
    Curr Clin Top Infect Dis; 2000; 20():63-91. PubMed ID: 10943519
    [No Abstract]   [Full Text] [Related]  

  • 23. [Efficiency of lomefloxacine in combined treatment of patients with multiresistant pulmonary tuberculosis complicated with nonspecific bronchopulmonary infection].
    Mishin VIu; Vasil'eva IA; Martynova LP
    Probl Tuberk; 1999; (6):20-2. PubMed ID: 10715950
    [No Abstract]   [Full Text] [Related]  

  • 24. Drug not considered a first-line agent.
    Lexchin J
    Can Fam Physician; 1998 Nov; 44():2376. PubMed ID: 9839049
    [No Abstract]   [Full Text] [Related]  

  • 25. New antibiotic approved for community-acquired infections.
    Nurse Pract; 1998 Jan; 23(1):94. PubMed ID: 9470200
    [No Abstract]   [Full Text] [Related]  

  • 26. Sparfloxacin: potential clinical and economic impact in the treatment of respiratory infections.
    Stein GE; Havlichek DH
    Pharmacotherapy; 1997; 17(6):1139-47. PubMed ID: 9399598
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The role of respiratory quinolone in treatment of respiratory tract infections: focusing on gatifloxacin].
    Kohno S; Watanabe A; Matsushima T
    Jpn J Antibiot; 2002 Jun; 55(3):247-58. PubMed ID: 12199109
    [No Abstract]   [Full Text] [Related]  

  • 28. Possible role for the new fluoroquinolones (levofloxacin, grepafloxacin, trovafloxacin, clinafloxacin, sparfloxacin, and DU-6859a) in the treatment of anaerobic infections: review of current information on efficacy and safety.
    Goldstein EJ
    Clin Infect Dis; 1996 Dec; 23 Suppl 1():S25-30. PubMed ID: 8953103
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics and pharmacodynamics of oral grepafloxacin in patients with acute bacterial exacerbations of chronic bronchitis.
    Forrest A; Chodosh S; Amantea MA; Collins DA; Schentag JJ
    J Antimicrob Chemother; 1997 Dec; 40 Suppl A():45-57. PubMed ID: 9484873
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Use of new quinolones in respiratory infections].
    Sanz Moreno J; Jiménez Rodríguez A
    Rev Clin Esp; 2000 Dec; 200(12):682-4. PubMed ID: 11234474
    [No Abstract]   [Full Text] [Related]  

  • 31. [Respiratory tract infections--laboratory tests usually unnecessary. New quinolones recommended by professional groups considered].
    Steiert P
    Fortschr Med; 1999 Feb; 117(6):41. PubMed ID: 10095302
    [No Abstract]   [Full Text] [Related]  

  • 32. Clinical experience with OPC-17116 in the treatment of gynaecological infections and its penetration into gynaecological tissues. Japanese Collaborative Study Group of OPC-17116 in Gynaecology.
    Matsuda S
    Drugs; 1995; 49 Suppl 2():395-8. PubMed ID: 8549375
    [No Abstract]   [Full Text] [Related]  

  • 33. Effectiveness of short-course therapy (5 days) with grepafloxacin in the treatment of acute bacterial exacerbations of chronic bronchitis.
    DeAbate CA; Bettis R; Munk ZM; Fleming H; Munn NJ; Riffer E; Bagby B; Giguere G; Collins JJ
    Clin Ther; 1999 Jan; 21(1):172-88. PubMed ID: 10090434
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetic study of a new quinolone, DW-116.
    Lee DK
    Drugs; 1995; 49 Suppl 2():323-5. PubMed ID: 8549349
    [No Abstract]   [Full Text] [Related]  

  • 35. Fluoroquinolones in upper respiratory tract infections.
    Spiteri M
    BMJ; 1994 Mar; 308(6929):657-8. PubMed ID: 8148733
    [No Abstract]   [Full Text] [Related]  

  • 36. Quinolones in the treatment of lower respiratory tract infections in adult patients.
    Carbon C
    Drugs; 1993; 45 Suppl 3():91-7. PubMed ID: 7689458
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of enrofloxacin in the treatment of respiratory pasteurellosis in rabbits.
    Broome RL; Brooks DL
    Lab Anim Sci; 1991 Dec; 41(6):572-6. PubMed ID: 1667200
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A critical review of the fluoroquinolones: focus on respiratory infections.
    Zhanel GG; Ennis K; Vercaigne L; Walkty A; Gin AS; Embil J; Smith H; Hoban DJ
    Drugs; 2002; 62(1):13-59. PubMed ID: 11790155
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Fluoroquinolones in the treatment of respiratory infections].
    Stahlmann R
    Pneumologie; 1999 Nov; 53(11):521-9. PubMed ID: 10613068
    [No Abstract]   [Full Text] [Related]  

  • 40. Use of newer quinolones for the treatment of intraabdominal infections: focus on clinafloxacin.
    Nord CE
    Infection; 1999; 27(3):166-72. PubMed ID: 10378126
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.